|
Treatment
Guidelines for HIV-Associated Wasting
Contributors
Bruce Polsky, MD; Donald Kotler, MD; and Corklin Steinhart, MD,
PhD
Bruce
Polsky, MD, Vice Chairman, Department of Medicine, Chief, Division
of Infectious Diseases, St. Luke's-Roosevelt Hospital Center, New
York, NY.
Donald
Kotler, MD, Professor of Medicine, Columbia University College
of Physicians and Surgeons, St. Luke's-Roosevelt Hospital Center,
New York, NY.
Corklin
Steinhart, MD, PhD, Medical Director, Florida AIDS Education
Training Center, University of South Florida, Mercy Hospital, Miami,
FL.
Supported
by an unrestricted educational grant from Serono, Inc.
These
guidelines represent the opinions and recommendations expressed
by participants of the Consensus Development Panel. They do not
necessarily reflect the opinions or recommendations of Serono, Inc.
Content may include references to the unlabeled use of a commercial
product or the investigational use of a product not yet approved
for the purpose discussed. Please consult the full prescribing information
before using any medications mentioned in this publication.
Introduction
History
of HIV-Associated Wasting
HIV-Associated
Wasting in the HAART ERA
Measuring
Body Composition
Definition
of HIV-Associated Wasting
Assessment
Protocol for Patients with HIV-Associated Wasting
General
Patient Management Protocol
Treatment
of Hypogonadal Patients
Treatment
with Recombinant Human Growth Hormone
Treatment
with Anabolic Steroids
Adjunctive
Treatments and Interventions
Expected
Clinical Outcomes and Conclusions
References
7/16/01
|
